Diminishes dark spots, acne scars, blemishes, and freckles
Phase 2 Trial Data : The highest tested dose was 12 mg , which resulted in average weight loss exceeding 24%
Patients with LN were excluded from such studies due to the potential necessity of acute immunosuppression ( Recently, we have published a pilot study in patients with LN on stable immunosuppressive treatment and non-immunosuppressive treatment with RAASi to whom a 10-mg dose of empagliflozin was added, obtaining a 50% reduction in residual proteinuria with minimal changes in eFGR and with few side effects ( GLP-1RA Glucagon-like peptide one receptor agonists (GLP-1RA) is a class B G protein-coupled receptor expressed in the pancreas and central nervous system but is also present in other organs such as the gut, kidneys, lungs, liver, heart, muscle, and peripheral nerves
Within the type 2 diabetes drug sector, valued at around USD 88 billion , its contribution is estimated at 20-25% based on treatment volumes and sales